NSEAppointment10 Jul 2026 · 10 Jul 2026, 10:53 pm

Appointment

Hindustan Construction Company Limited · HCC

✦ AI SummaryMgmt Change

Hindustan Construction Company Limited has appointed Mr. Nakul Pasricha as a Non-Executive Independent Director, effective July 10, 2026, for a term of 5 years, subject to shareholder approval.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Hindustan Construction Company Limited has informed the Exchange regarding Appointment of Mr. Nakul Pasricha as Non- Executive Independent Director of the company w.e.f. July 10, 2026.

Attachments (1)

📄

HCC_10072026225315_Exchange.pdf

pdf

Download →
View document text
HCC/SEC/APT/2026 July 10, 2026 BSE Limited National Stock Exchange of India limited The Corporate Relationship Dept, Exchange Plaza, Phiroze Jeejeebhoy Towers, Sandra Kurla Complex, Dalal Street, Sandra (East), Mumbai-400 001 Mumbai-400 051 Scrip Codes: 500185, 974246, 974247, Symbol- HCC 974 249 & 97 4250 Dear Sir I Madam, Sub :Intimation under Regulations 30 and 51 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to the provisions of Regulations 30 and 51 read with Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly take note that based on the recommendations of the Nomination and Remuneration Committee of the Company, the Board of Directors, vide its Circular Resolution passed today i.e. July 10, 2026, has appointed Mr. Nakul Pasricha (DIN: 03176843), as an Additional (Non-Executive Independent) Director of the Company, not liable to retire by rotation, for a term of 5 (five) consecutive years with effect from July 10, 2026. The abovementioned appointment is subject to obtaining approval of the Members of the Company in the ensuing General Meeting or within three months from the date of his appointment, whichever is earlier as per Regulation 17(1 C) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take note that Mr. Nakul Pasricha is not debarred from holding the office of Director by virtue of any SEBI order or order of any other such Authority. The disclosure pursuant to SEBI Master Circular No. H0/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026 is enclosed as Annexure A. Kindly take the above on record. Yours sincerely, For Hindustan Construction Company Ltd. Nitesh Kumar Jha Company Secretary Encl.: As above. Hindustan Construction Co ltd Hincon House, lal Bahadur Shastri Marg, Vikhroli (West), Mumbai 400 083, India Tel : + 91 22 2577 5959 Fax : + 91 22 2577 7568 www .hccindia.com Annexure A The disclosure pursuant to SEBI Master Circular No. H0/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026 Sr. Particulars Details 1. Reason for change viz. Appointment appointment, re-appointment, resignation, removal, death or otherwise 2. Date of appointment/re- Appointed Mr. Nakul Pasricha (DIN: 03176843), as an appointment/cessation (as Additional (Non-Executive Independent) Director of the applicable) & term of Company, not liable to retire by rotation, for a term of 5 appointment/re-appointment (five) consecutive years with effect from July 10, 2026, subject to obtaining approval of the Members of the Company in the ensuing General Meeting or within three months from the date of his appointment, whichever is earlier as per Regulation 17( 1 C) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 3. Brief Profile Nakul Pasricha is a versatile business leader with over 27 years' experience spanning multiple geographies, industries and company sizes. He is the MD & CEO for PharmaSecure, a leading provider of technology enabled anti-counterfeiting solutions to the pharmaceutical and other industries in India, Africa and beyond. At PharmaSecure, Mr. Pasricha first led the development of patented technology solutions to protect medicines and supply chains against counterfeiting and then invested in and took on leadership of the company, growing it to serve over 1 00 companies in the pharmaceutical and other sectors, with more than 10 billion packs protected to date in India and Africa. He was granted a patent as a co inventor of the technology engine that drives PharmaSecure's authentication solution. In addition to his primary role, Mr. Pasricha has served on the governing body of the Authentication Solution Providers' Association (ASPA), a not-for-profit body devoted to research, awareness and advocacy of solutions to prevent counterfeiting. He has been elected President of ASPA for two terms and is currently Vice President. In this role, Mr. Pasricha has been a strong public advocate of stringent measures to curb the loss of life and revenue from counterfeiting across sectors. He has led the publication of the seminal report on www .hccindia.com counterfeiting, "A State of Counterfeiting in India", frequently used as a reference to better understand the issue from a consumer perspective. He has also overseen the launch and growth of the conference series, "Traceability and Authentication Forum", bringing together stakeholders from industry, government and the solution provider ecosystem. Mr. Pasricha also serves on the National Intellectual Property Rights Committee of the Confederation for Indian Industry (CII) where he contributes to conversations around IPR and counterfeiting. Mr. Pasricha is Co-Promoter and Director of Flexing It, India and Asia's largest platform for independent consultants and professional freelance talent. Founded in 2014, Flexinglt® is a category leader in on-demand talent solutions, connecting 2000+ organisations with 10 0,000+ vetted consultants and experts across strategy, operations, technology, and transformation. Recognised as a high-growth startup in APAC by the Financial Times and a strategic partner to large enterprise clients, Flexing It® enables rapid access to the right expertise through flexible, outcome-driven engagement models. Previously, Mr. Pasricha served in technology leadership roles across a variety of organizations, starting his career at Citibank (U.S.A.), overseeing global technology implementations. He was part of the team at the forefront of IT outsourcing to India ahead of Y2K. After moving to India in 2005, Mr. Pasricha served as the Chief Information Officer of General Electric's consumer finance division, overseeing a team of 120 people implementing and supporting financial systems for the loans business, and managing projects for SBI Cards, which was at that time a JV with GE. Mr. Pasricha has participated as a speaker or moderator in conferences organized by Cll, Assocham, PHDCII and other organizations, and contributed to counterfeiting related stories in leading publications including: Business World, Business Standard, Economic Times, The Hindu, Express Pharma, Financial Times, Deutsche Welle and Channel News Asia. Mr. Pasricha has a B.A. in Mathematics and Computer Science from Gettysburg College, and an M.S. in Computer Science from the University of Maryland at College Park. He is an Indian citizen and resident. www .hccindia.com He serves as Board Director for PharmaSecure Inc. (USA), PharmaSecure PAS India Pvt. Ltd., Flexing It Services Pte Ltd. (Singapore) and Flexing It Services Pvt. Ltd. 4. Disclosure of relationships Mr. Nakul Pasricha is not related to any Director of the between Directors Company. www.hccindia.com